Table 4.
Primary outcome
| Variable | GDHT group | Usual care group | Absolute difference (95% CI) | p |
|---|---|---|---|---|
| (n = 64) | (n = 64) | |||
| Composite endpoint | 53 (40–66) | 44 (31–57) | 9.4 (−7.8 to 25.8) | 0.3 |
| Mortality | 14 (7–25) | 9 (4–19) | 4.7 (−6.9 to 16.4) | 0.4 |
| Stroke | 0 (0–6) | 2 (0–8) | −1.6 (−8.3 to 4.2) | 0.9 |
| AKI | 51 (36–61) | 39 (27–52) | 9.4 (− 7.6 to 25.6) | 0.2 |
| ARDS | 5 (2–15) | 2 (0–8) | 4.7 (−3.1 to 13.5) | 0.4 |
| Acute myocardial infarction | 2 (0–8) | 5 (0.9–13) | −3.1 (− 11.4 to 4.3) | 0.6 |
| Acute heart failure | 0 (0–6) | 2 (0–8) | −1.6 (− 8.3 to 4.2) | 0.5 |
| Mesenteric ischemia | 2 (0–8) | 0 (0–6) | 1.6 (−4.2 to 8.3) | 0.9 |
| Peripheral vascular ischemia | 0 (0–6) | 3 (0.3–11) | − 3.1 (− 10.7 to 3.0) | 0.5 |
| Pulmonary embolism | 0 (0–6) | 0 (0–6) | – | – |
| Deep wound infection | 3 (0.3–11) | 8 (3–17) | −4.7 (− 14.2 to 4.1) | 0.4 |
| Reoperation | 8 (3–17) | 5 (0.9–13) | 3.1 (− 6.2 to 12.8) | 0.7 |
Data presented as % (95% CI)
GDT goal-directed hemodynamic therapy, CI confidence interval, AKI acute kidney injury, ARDS acute respiratory distress syndrome